Get started
Author

Iosif M. Gershteyn

Observed names: Gershteyn, Iosif M., Iosif Gershteyn, Iosif M Gershteyn
ORCID: 0000-0001-7921-1369
Observed ORCID: 0000-0001-7921-1369
OpenAlex ID: A5053530934
Disagreement on foundational principles of biological aging
2024 · Vadim N Gladyshev, Benjamin Anderson, et al. · PNAS Nexus · 63
PDF
Immunodietica: A data-driven approach to investigate interactions between diet and autoimmune disorders
2019 · Iosif M. Gershteyn, Leonardo M.R. Ferreira · Journal of Translational Autoimmunity · 22
PDF
Immunodietica: interrogating the role of diet in autoimmune disease
2020 · Iosif M Gershteyn, Andrey A Burov, et al. · International Immunology · 16
PDF
A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression
2025 · Victor S. Goldmacher, Iosif Gershteyn, et al. · Scientific Reports · 7
Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication
2024 · Victor S Goldmacher, Iosif M Gershteyn, et al. · Antibody Therapeutics · 5
PDF
Quantum Horizon: An evaluation of quantum computing as a threat to Bitcoin and Ethereum
2026 · Gershteyn, Iosif M., Alber, Jacob A. · arXiv (Cornell University)
PDF
Decoherence via Demyelination Hypothesis (DDH): A Mechanism of Cognitive Decline During Aging
2026 · Iosif M. Gershteyn, Nikola T. Markov, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Cytotoxic activity and safety characterization of IMV-M™, a MUC16 × DR5 bispecific antibody
2026 · Victor S Goldmacher, Iosif M Gershteyn · Antibody Therapeutics
Abstract 3176: Tumor-selective regression through MUC16-guided DR5 (TNFRSF10B) clustering by the bispecific anti-MUC16×anti-DR5 antibody IMV-M™
2026 · Iosif M. Gershteyn, Viktor Goldmakher · Cancer Research
Integrated Cytotoxic and Safety Mechanism of IMV-M™, a MUC16×DR5 Bispecific Antibody
2026 · Victor S. Goldmacher, Iosif M. Gershteyn · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Market Microstructure and Emission Policy in Decentralized Incentive Networks: A Flow-Based Simulation of Subnet Culling, Short Selling, and Capacity Expansion in Bittensor
2026 · Iosif Gershteyn · SSRN Electronic Journal
The Judgement Economy: An Operating Model for Knowledge Work in the Age of AI Agents
2026 · Jacob Alber, Iosif Gershteyn · SSRN Electronic Journal
When Smoothing Blocks Markets: Why Short Selling Improves Price-Based Allocation but Degrades Flow-Smoothed Allocation
2026 · Albert A. Zevelev, Iosif Gershteyn · SSRN Electronic Journal
A bispecific antibody overcomes limitations of prior strategies to achieve effective and tumor-selective Death Receptor 5 (DR5) clustering
2025 · Victor S. Goldmacher, Iosif M. Gershteyn, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Fertility and COVID-19 vaccination
2022 · Iosif M. Gershteyn · Exploration of Immunology
PDF
Immunodietica: towards a data-driven approach to dissect interactions between diet and autoimmune disease
2020 · Leonardo Ferreira, Andrey A. Burov, et al. · The Journal of Immunology
Regular residential wastewater monitoring to locate emerging disease hotspots prior to onset of clinical symptoms during pandemics including COVID-19
2020 · Mikhail L. Gershteyn, Arkady Gershteyn, et al.
Evolution is Viral: The Theory of Collective Discontinuous Evolution
2010 · Mikhail L. Gershteyn, Iosif Gershteyn · Nature Precedings
PDF
Evolution is Viral: The Theory of Collective Discontinuous Evolution
2010 · Mikhail L. Gershteyn, Mikhail L. Gershteyn, et al. · Nature Precedings
Works count: 19
Citation count: 112
H-index: 5
I10-index: 3
Year
Topic
Type